Biblio Discovery — Demo Discovery Service

16 results for "Alberto Delaidelli"

Showing 1–16 · 0.33 seconds · RSS

  1. Journal Article Full text

    Recent Advances in the Diagnosis and Treatment of Brain Tumors

    Alberto Delaidelli; Alessandro Moiraghi

    Brain Sciences, Vol. 14 No. 3 · 2024 · English · DOAJ Scopus

    Brain tumors represent some of the most aggressive malignancies [...]

  2. Journal Article

    RNA modifications in brain tumorigenesis

    Albert Z. Huang; Alberto Delaidelli; Poul H. Sorensen

    Acta Neuropathologica Communications, Vol. 8 No. 1 · 2020 · English · DOAJ Scopus

    Abstract RNA modifications are emerging as critical regulators in cancer biology, thanks to their ability to influence gene expression and the predominant protein isoforms expressed during cell proliferation, migration, and other pro-oncogenic properties. The reversibility and dynamic nature of…

  3. Journal Article Full text

    Pediatric Brain Tumours: Lessons from the Immune Microenvironment

    Betty Yao; Alberto Delaidelli; Hannes Vogel et al.

    Current Oncology, Vol. 30 No. 5 · 2023 · English · DOAJ Scopus

    In spite of recent advances in tumour molecular subtyping, pediatric brain tumours (PBTs) remain the leading cause of cancer-related deaths in children. While some PBTs are treatable with favourable outcomes, recurrent and metastatic disease for certain types of PBTs remains challenging and is…

  4. Journal Article

    Surgical management of sellar arachnoid cyst: state of the art and systematic review

    Michele Pio Fabrizio; Gianpaolo Jannelli; Francesco Calvanese et al.

    Frontiers in Neurology, Vol. 16 · 2025 · English · DOAJ Scopus

    IntroductionSellar arachnoid cysts are rare intracranial lesions with variable clinical presentations, making their optimal management uncertain. This systematic review consolidates current knowledge on their epidemiology, radiological features, surgical management, and outcomes.Materials and…

  5. Journal Article

    Spatial transcriptomics reveals the molecular signatures of prodromal and advanced α-synucleinopathy

    Lin Lin; Nanna M. Jensen; Alberto Delaidelli et al.

    iScience, Vol. 29 No. 3 · 2026 · English · DOAJ Scopus

    Summary: A pathological role of α-synuclein (aSyn) aggregation in the etiology of Parkinson disease (PD) is well established. Here, we applied spatial transcriptomics (ST) on brain sections derived from a rodent mouse model of α-synucleinopathy (transgenic M83+/+ line). Our ST data revealed that…

  6. Journal Article

    The EIF4EBP1 gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in medulloblastoma

    Laura Hruby; Katerina Schaal; Alberto Delaidelli et al.

    Cell Death Discovery, Vol. 11 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Medulloblastoma (MB) is the most common malignant brain tumor in childhood and is stratified into four molecular groups ‒ Wingless and Int-1 (WNT), Sonic hedgehog (SHH), Group 3 and Group 4. Group 3 MB patients exhibit the poorest prognosis, with a 5-year overall survival of

  7. Journal Article

    The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation

    Jonathan K. M. Lim; Arash Samiei; Alberto Delaidelli et al.

    Cell Death and Disease, Vol. 15 No. 7 · 2024 · English · DOAJ Scopus

    Abstract Eukaryotic elongation factor 2 (eEF2) kinase (eEF2K) is a stress-responsive hub that inhibits the translation elongation factor eEF2, and consequently mRNA translation elongation, in response to hypoxia and nutrient deprivation. EEF2K is also involved in the response to DNA damage but its…

  8. Journal Article

    Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity

    Asad Jan; Brandon Jansonius; Alberto Delaidelli et al.

    Acta Neuropathologica Communications, Vol. 6 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Parkinson disease (PD) is the second most common neurodegenerative disorder and the leading neurodegenerative cause of motor disability. Pathologic accumulation of aggregated alpha synuclein (AS) protein in brain, and imbalance in the nigrostriatal system due to the loss of dopaminergic…

  9. Journal Article

    α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response

    Alberto Delaidelli; Mette Richner; Lixiang Jiang et al.

    Acta Neuropathologica Communications, Vol. 9 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Circumstantial evidence points to a pathological role of alpha-synuclein (aSyn; gene symbol SNCA), conferred by aSyn misfolding and aggregation, in Parkinson disease (PD) and related synucleinopathies. Several findings in experimental models implicate perturbations in the tissue…

  10. Journal Article

    Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors

    Johanna Lena Theruvath; Elena Sotillo; Christopher Mount et al.

    Nature Medicine · 2020 · English · OpenAlex Scopus

    Atypical teratoid/rhabdoid tumors (ATRTs) typically arise in the central nervous system (CNS) of children under 3 years of age. Despite intensive multimodal therapy (surgery, chemotherapy and, if age permits, radiotherapy), median survival is 17 months1,2. We show that ATRTs robustly express…

  11. Journal Article

    Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors

    David M Barrett; Daniel Martinez; Tiffany Smith et al.

    Journal for ImmunoTherapy of Cancer, Vol. 10 No. 9 · 2022 · English · DOAJ Scopus

    Background Pediatric brain tumors are the leading cause of cancer death in children with an urgent need for innovative therapies. Glypican 2 (GPC2) is a cell surface oncoprotein expressed in neuroblastoma for which targeted immunotherapies have been developed. This work aimed to characterize GPC2…

  12. Journal Article

    Surface and global proteomics identify ROR2 and other proteins as potentially actionable immunotherapeutic targets in osteosarcoma

    Brian Mooney; Xiaojie Chu; Gian Luca Negri et al.

    Cell Reports, Vol. 45 No. 9 · 2026 · English · DOAJ Scopus

    Summary: Osteosarcoma (OS) is the most common human primary bone cancer, primarily affecting children and young adults. While the survival rate of patients diagnosed with localized OS is ∼65%, this decreases to ∼20% for patients with metastatic disease, and recurrent disease remains largely…

  13. Journal Article

    Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours

    Arash Nabbi; Pengbo Beck; Alberto Delaidelli et al.

    Genome Medicine, Vol. 15 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Background Cancer immunotherapies including immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR) T-cell therapy have shown variable response rates in paediatric patients highlighting the need to establish robust biomarkers for patient selection. While the tumour…